II
CYTK icon

Inspire Investing’s Cytokinetics CYTK Stock Holding History

Inspire Investing’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$678K Buy
7,959
+137
+2% +$9.84K 0.03% 767
2026
Q1 		$516K Buy
7,822
+492
+7% +$31.3K 0.03% 632
2025
Q4 		$466K Sell
7,330
-862
-11% -$53.6K 0.04% 661
2025
Q3 		$450K Sell
8,192
-3,696
-31% -$152K 0.04% 714
2025
Q2 		$393K Buy
11,888
+3,337
+39% +$116K 0.04% 397
2025
Q1 		$344K Buy
8,551
+47
+0.6% +$2.16K 0.04% 559
2024
Q4 		$400K Buy
8,504
+616
+8% +$32K 0.04% 631
2024
Q3 		$416K Buy
7,888
+1,317
+20% +$73.4K 0.04% 377
2024
Q2 		$356K Buy
6,571
+1,484
+29% +$89.6K 0.04% 389
2024
Q1 		$357K Buy
5,087
+605
+13% +$46.8K 0.04% 717
2023
Q4 		$374K Sell
4,482
-5,882
-57% -$213K 0.04% 778
2023
Q3 		$305K Buy
10,364
+753
+8% +$25.1K 0.04% 727
2023
Q2 		$314K Buy
9,611
+1,927
+25% +$71.3K 0.04% 634
2023
Q1 		$270K Buy
7,684
+2,521
+49% +$103K 0.03% 761
2022
Q4 		$237K Buy
5,163
+828
+19% +$35.6K 0.03% 420
2022
Q3 		$210K Sell
4,335
-1,027
-19% -$49.4K 0.03% 348
2022
Q2 		$211K Sell
5,362
-26,297
-83% -$1.06M 0.03% 641
2022
Q1 		$1.17M Buy
31,659
+26,192
+479% +$931K 0.13% 145
2021
Q4 		$249K Sell
5,467
-1,595
-23% -$61.5K 0.03% 489
2021
Q3 		$252K Buy
+7,062
New +$208K 0.03% 354

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Inspire Investing's CYTK Position: Q2 2026 in Review

Inspire Investing increased its Cytokinetics (CYTK) stake by 1.8% in Q2 2026, buying an estimated $9.84K and bringing the position to 7,959 shares worth $678K. The position accounts for 0.03% of the portfolio, ranked #767.

Inspire Investing first reported a position in CYTK in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.17M in Q1 2022. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Inspire Investing held 7,959 shares of Cytokinetics worth $678K as of Q2 2026.
  • Inspire Investing bought 137 Cytokinetics shares in Q2 2026, an estimated $9.84K.
  • Cytokinetics made up 0.03% of Inspire Investing's portfolio in Q2 2026, its #767 holding.
  • Inspire Investing first reported a position in Cytokinetics in Q3 2021 and has held it in 20 quarters since.
  • Inspire Investing's Cytokinetics position peaked at $1.17M in Q1 2022.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.